Trial NCT04621123
Publication Alemany A, Lancet Respir Med (2022) (published paper)
Primary outcome on the report: Incidence of hospitalisation within 28 days from baseline; change in viral load in nasopharyngeal swabs from baseline to day 7.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.